Good Fellow Healthcare Holdings Limited (8143) AI Stock Analysis

• Market Cap: HK$158.95M
• Dividend Yield: N/A
• Average Volume (3M): 503.41K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.09
• Revenue Growth: -58.63%
• EPS Growth: 40.85%
• Country: HK
• Employees: 118
• Sector: Healthcare
• Sector Strength: 47
• Industry: Medical - Care Facilities
• EPS (TTM): -0.02
• Shares Outstanding: 1,127,299,900
• 10 Day Avg. Volume: 554,981
• 30 Day Avg. Volume: 503,407
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 46 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

The overall stock score is primarily impacted by the company's poor financial performance, characterized by declining revenues, substantial losses, and negative equity. Technical analysis provides some support with short-term bullish momentum, but the negative P/E ratio and lack of dividend yield weigh heavily on the valuation. The absence of earnings call data and corporate events leaves these areas unaddressed.

Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model

Company Description

Good Fellow Healthcare Holdings Limited (8143) is a company engaged in the healthcare sector, primarily focusing on providing a range of medical and healthcare services. The company specializes in offering innovative healthcare solutions, including medical equipment distribution, healthcare management services, and wellness programs. Its core products and services aim to enhance patient care and improve health outcomes, catering to both individual consumers and institutional clients.

How the Company Makes Money

Good Fellow Healthcare Holdings Limited generates revenue through multiple streams, including the sale of medical equipment and supplies to healthcare institutions and professionals. The company also earns income from healthcare management services, which involve consulting and operational support for healthcare facilities. Additionally, revenue is derived from wellness programs designed to promote health and prevent illness among consumers. Strategic partnerships with healthcare providers and suppliers further enhance the company's market reach and contribute to its earnings, allowing it to leverage synergies and expand its service offerings.

Good Fellow Healthcare Holdings Limited Financial Statement Overview

Summary

Good Fellow Healthcare Holdings Limited is facing significant financial challenges, as evidenced by declining revenues, persistent net losses, and a weakening balance sheet. The company is under pressure with high leverage and cash flow constraints, suggesting a need for strategic restructuring to improve financial health and performance.

Income Statement

The company has experienced a significant decline in revenue over the past few years, with a revenue decrease from $144.59 million in 2020 to $38.96 million in 2024. Gross profit margin has also deteriorated, alongside negative EBIT and net profit margins, indicating operational challenges. The continued negative net income suggests persistent profitability issues.

Balance Sheet

The balance sheet shows a high leverage with a debt-to-equity ratio increasing due to rising total liabilities and decreased equity. The equity ratio has decreased significantly over the years, indicating higher financial risk. Stockholders' equity has been notably reduced from 2020 to 2024, reflecting financial instability.

Cash Flow

The company's cash flow statements reveal a volatile and declining cash flow position. Negative free cash flow and operating cash flow over the recent years highlight liquidity issues. Although there was a positive operating cash flow in 2021, overall cash flow management remains a concern due to substantial negative free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	23.27M	16.12M	38.96M	55.35M	54.24M	53.89M
Gross Profit	7.46M	8.37M	18.67M	27.01M	26.66M	26.45M
EBITDA	-4.41M	1.86M	-10.12M	1.83M	4.38M	-23.55M
Net Income	-2.35M	-10.13M	-17.11M	-5.88M	-12.69M	-30.18M
Balance Sheet
Total Assets	24.67M	9.83M	29.15M	41.70M	60.45M	191.38M
Cash, Cash Equivalents and Short-Term Investments	1.92M	4.14M	3.88M	18.36M	25.15M	44.89M
Total Debt	10.84M	10.53M	12.23M	4.49M	7.36M	29.73M
Total Liabilities	16.00M	16.59M	27.74M	22.32M	34.08M	158.48M
Stockholders Equity	11.69M	-6.51M	4.36M	22.19M	29.59M	40.23M
Cash Flow
Free Cash Flow	-15.78M	2.58M	-15.35M	-3.84M	-24.51M	-21.21M
Operating Cash Flow	-1.29M	2.62M	-854.00K	-1.32M	-22.93M	1.25M
Investing Cash Flow	-1.68M	-1.57M	-14.46M	5.74M	2.19M	-24.28M
Financing Cash Flow	2.39M	1.06M	4.36M	-2.75M	-5.61M	4.83M

Good Fellow Healthcare Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.14
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Positive. The current price of 0.14 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.13, and above the 200-day MA of 0.08, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 64.76 is Neutral, neither overbought nor oversold. The STOCH value of 95.63 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8143.

Good Fellow Healthcare Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2293	75 Outperform	HK$221.35M	9.26	10.72%	4.55%	-22.12%	-28.95%
8357	60 Neutral	HK$112.32M	―	-10.31%	―	-11.68%	-71.01%
8161	58 Neutral	HK$18.30M	2.27	105.83%	―	-8.48%	―
8307	56 Neutral	HK$86.89M	―	-44.60%	―	-8.20%	-10.39%
Sector *	51 Neutral	$7.83B	-0.18	-40.10%	2.29%	21.46%	-2.03%
8143	46 Neutral	HK$158.95M	―	-18.22%	―	-58.63%	40.85%
8437	41 Neutral	HK$10.59M	―		―	14.64%	-81.95%